Literature DB >> 26957042

The impact of Salmonella Enteritidis on lipid accumulation in chicken hepatocytes.

Chia-Lan Wang1, Yang-Chi Fan1, Chinling Wang2, Hsiang-Jung Tsai1,3, Chung-Hsi Chou1.   

Abstract

Salmonella enterica serovar Enteritidis (SE) is a public health concern and infected chickens serve as a reservoir that potentially transmits to humans through food. Although SE seldom causes systemic disease in chickens, virulent SE strains can colonize in intestines and lead a persistent infection of the liver. The liver is the primary organ for lipid metabolism in chickens and the site for production and assembly of main components in yolk. We performed a time-course experiment using LMH-2A cells that were infected with SE and co-incubated with β-oestradiol to evaluate if SE infection affected lipid metabolism and subsequently changed lipoprotein formation for egg yolk. The results indicated that lipid accumulation significantly increased in infected LMH-2A cells while the viability of these cells was only slightly decreased. The mRNA expressions of lipid transportation and most lipogenetic genes including sterol regulatory element binding protein 1, acetyl-CoA carboxylase, fatty-acid synthase, long-chain-fatty-acid-CoA ligase 1, peroxisome proliferator-activated receptor-γ, and very-low-density lipoproteins (VLDLs) II were significantly up-regulated while the expression of lipogenetic-related stearoyl-CoA denaturase 1 was down-regulated. Moreover, decline in lipid transportation of hepatocytes was evidenced by the down-regulation of oestrogen receptor α which promotes VLDLy formation, an increase of intra-cellular accumulation of Apoprotein B (ApoB) protein, and a decrease of cellular excretion of VLDL protein. Conclusively, SE infection could elevate lipid synthesis and reduce lipid transportation in the chicken hepatocytes. These changes may lead excessive lipid accumulation in liver and slower lipoprotein deposition in yolk.

Entities:  

Keywords:  LMH-2A cells; Salmonella Enteritidis; VLDL; egg production; liver lipid accumulation

Mesh:

Substances:

Year:  2016        PMID: 26957042     DOI: 10.1080/03079457.2016.1162280

Source DB:  PubMed          Journal:  Avian Pathol        ISSN: 0307-9457            Impact factor:   3.378


  5 in total

1.  Iron oxide nanozyme suppresses intracellular Salmonella Enteritidis growth and alleviates infection in vivo.

Authors:  Shourong Shi; Shu Wu; Yiru Shen; Shan Zhang; Yunqi Xiao; Xi He; Jiansen Gong; Yuhua Farnell; Yan Tang; Yixin Huang; Lizeng Gao
Journal:  Theranostics       Date:  2018-11-29       Impact factor: 11.556

2.  Intestinal Mucosal Immunity-Mediated Modulation of the Gut Microbiome by Oral Delivery of Enterococcus faecium Against Salmonella Enteritidis Pathogenesis in a Laying Hen Model.

Authors:  Shimeng Huang; Xiaoping Rong; Meiling Liu; Zhongjun Liang; Yanqiang Geng; Xinyue Wang; Jianyun Zhang; Cheng Ji; Lihong Zhao; Qiugang Ma
Journal:  Front Immunol       Date:  2022-03-15       Impact factor: 7.561

3.  Nutrient sources differ in the fertilised eggs of two divergent broiler lines selected for meat ultimate pH.

Authors:  Angélique Petit; Sophie Réhault-Godbert; Lydie Nadal-Desbarats; Estelle Cailleau-Audouin; Pascal Chartrin; Emilie Raynaud; Justine Jimenez; Sophie Tesseraud; Cécile Berri; Elisabeth Le Bihan-Duval; Sonia Métayer-Coustard
Journal:  Sci Rep       Date:  2022-04-01       Impact factor: 4.996

4.  Pathogenesis-Related Gene Expression in Response to Trachyspermum ammi Supplementation Along With Probiotics in Chicken Salmonellosis and Insights in Drug Therapeutics.

Authors:  Zulfqarul Haq; Syed Mudasir Ahmad; Ishrat Bashir; Mashooq Ahmad Dar; Afnan Saleem; Azmat Alam Khan; Mohammad Iqbal Yatoo; Shabir Mir; Ankur Rastogi; Mohd Isfaqul Hussain; Riaz A Shah; Basharat Bhat
Journal:  Front Vet Sci       Date:  2022-06-02

5.  The dietary combination of essential oils and organic acids reduces Salmonella enteritidis in challenged chicks.

Authors:  S Zhang; Y R Shen; S Wu; Y Q Xiao; Q He; S R Shi
Journal:  Poult Sci       Date:  2019-12-01       Impact factor: 3.352

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.